切换至 "中华医学电子期刊资源库"
高级检索
中华关节外科杂志(电子版)

中华关节外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (06) : 680 -686. doi: 10.3877/cma.j.issn.1674-134X.2021.06.005

临床论著

二期翻修治疗培养阴性膝关节假体周围感染
王华溢1, 杨重飞1, 陈永锋1, 孙强1, 朱锦宇2, 张大伟1,†(), 朱庆生1   
  1. 1. 710032　西安，空军军医大学附属西京医院骨科
    2. 518000　深圳，南方科技大学医院骨科医学部
  • 收稿日期:2021-01-20 出版日期:2021-12-01
  • 通信作者: 张大伟

Treatment of culture-negative periprosthetic joint infection after total knee arthroplasty

Huayi Wang1, Chongfei Yang1, Yongfeng Chen1, Qiang Sun1, Jinyu Zhu2, Dawei Zhang1,†(), Qingsheng Zhu1   

  1. 1. Department of Orthopaedics, Xijing Hospital of Airforce Medical University, Xi'an 710032, China
    2. Department of Orthopaedics, Southern University of Science and Technology Hospital, Shenzhen 518000, China
  • Received:2021-01-20 Published:2021-12-01
  • Corresponding author: Dawei Zhang
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王华溢, 杨重飞, 陈永锋, 孙强, 朱锦宇, 张大伟, 朱庆生. 二期翻修治疗培养阴性膝关节假体周围感染[J]. 中华关节外科杂志(电子版), 2021, 15(06): 680-686.

Huayi Wang, Chongfei Yang, Yongfeng Chen, Qiang Sun, Jinyu Zhu, Dawei Zhang, Qingsheng Zhu. Treatment of culture-negative periprosthetic joint infection after total knee arthroplasty[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2021, 15(06): 680-686.

目的

回顾性分析二期翻修治疗细菌培养结果为阴性的膝关节假体周围感染(PJI)的临床结果。

方法

检索2010年至2017年西京医院关节外科收治的人工膝关节置换术后PJI，排除急性感染、培养阳性和一期翻修的病例，纳入慢性感染且微生物培养结果为阴性的病例共27例，所有患者均采用二期翻修手术治疗，术中使用抗生素骨水泥，术后给予6周抗生素治疗(静脉输入3周+口服左氧氟沙星+利福平胶囊3周)的方案。感染持续时间、是否使用抗生素等因素与窦道形成的相关性采用logistic回归分析。

结果

纳入的27个病例中，感染治愈共26例(96.3%)，其中保留关节功能的24例(88.9%)，经关节融合治愈的患者2例，感染控制失败的1例(3.7%)。性别、年龄、是否使用抗生素、感染持续时间、C反应蛋白、血沉、白细胞计数、中性粒细胞百分比、D-二聚体等因素与窦道形成无显著相关性(均为P>0.05)。

结论

采用二期翻修+万古霉素/妥布霉素联合抗生素骨水泥，术后采用静滴头孢菌素的抗感染治疗，可以获得较好的治愈率并保留关节功能；但因缺乏对照且病例数较少，该方案的有效性尚需进一步论证。

关键词: 关节假体, 感染, 关节成形术，置换，膝, 再手术, 抗菌药, 骨水泥
Objective

To retrospectively evaluate the effect of two-stage revision on periprosthetic knee infections with negative cultured result.

Methods

Twenty-seven cases of microorganism culture negative periprosthetic joint infections(PJI) after total knee arthroplasty from January 2010 to December 2017 were collected for this study. The treatment included using antibiotic-loaded bone cement spacer, post-operative parenteral antibiotic for three weeks, following by oral levofloxacin and rifampicin for three weeks. The successful rate of treatment for periprosthetic knee infections were evaluated. Logistic regression was used to analyze the correlation between sinus tract formation and duration of infection, antibiotic usage, etc.

Results

A total of 27 cases of culture-negative PJI, of which 26 cases were cured, success rate of infection treatment was 96.3%, 24 cases(88.9%) preserved functional knees, two cases were cured by arthrodesis. Only one case failed to be eradicated infection, the failure rate was 3.7%. Gender, age, time of preoperative antibiotic infection control, C-reactive protein, erythrocyte sedimentation rate, white blood cell count, neutrophil percentage, D-dimer and other factors had no significant correlation with sinus tract formation(all P>0.05).

Conclusions

The culture-negative periprosthetic knee infections can be treated successfully by second-stage revision using antibiotic-loaded bone cement (vancomycin, tobramycin) implantation combined with intravenous cephalosporin infusions, the strategy may obtain a reasonable cure rate and preserve joint function. However, the effectiveness of this treatment strategy needs to be further demonstrated due to the lack of control group and short of cases.

Key words: Joint prosthesis, Infections, Arthroplasty, replacement, knee, Reoperation, Anti-bacterial agents, Bone cements
表1 窦道相关因素的logistic回归
窦道相关因素 参数估计 标准误 Waldχ2 P值 OR值 OR值的95%CI
性别 1.658 1.917 0.748 0.387 5.248 (0.123，224.609)
年龄(≤65岁/>65岁) -2.422 2.389 1.028 0.311 0.089 (<0.001，9.586)
术前抗生素(是/否) -12.941 220.788 0.003 0.953 0.000 (<0.001，>999.999)
旷置后感染控制期* 0.197 0.464 0.180 0.671 1.218 (0.490，3.026)
C反应蛋白 0.052 0.059 0.757 0.384 1.053 (0.937，1.183)
红细胞沉降率 -0.123 0.146 0.709 0.400 0.884 (0.664，1.178)
白细胞计数 -0.143 0.403 0.126 0.723 0.867 (0.393，1.910)
中性粒细胞百分比 0.167 0.194 0.748 0.387 1.182 (0.809，1.728)
D-二聚体 -0.298 0.884 0.114 0.736 0.742 (0.131，4.192)
[1]
Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States[J]. J Arthroplasty, 2012, 27(8 Suppl): 61-65.e1.
[2]
Ibrahim MS, Raja S, Khan MA, et al. A multidisciplinary team approach to two-stage revision for the infected hip replacement: a minimum five-year follow-up study[J]. Bone Joint J, 2014, 96-b(10): 1312-1318.
[3]
张先龙，沈灏，王加兴．人工关节假体感染诊治的研究进展[J/CD]．中华关节外科杂志(电子版)，2017，11(4)：327-330.
[4]
Palan J, Nolan C, Sarantos K, et al. Culture-negative periprosthetic joint infections[J]. EFORT Open Rev, 2019, 4(10): 585-594.
[5]
Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection[J]. Clin Infect Dis, 2007, 45(9): 1113-1119.
[6]
Choi HR, Kwon YM, Freiberg AA, et al. Periprosthetic joint infection with negative culture results: clinical characteristics and treatment outcome[J]. J Arthroplasty, 2013, 28(6): 899-903.
[7]
Peel TN, Dowsey MM, Aboltins CA, et al. Culture negative prosthetic joint infection-a description of current treatment and outcomes[J/OL]. Clin Microbial 2013, 2(2)：1000106.DOI: 10.4172/2327-5073.1000106.
[8]
Reisener M, Perka C. Do culture-negative periprosthetic joint infections have a worse outcome than culture-positive periprosthetic joint infections? A systematic review and meta-analysis[J/OL]. Biomed Res Int, 2018, Jul(12): 6278012. DOI: 10.1155/2018/6278012.
[9]
Tan TL, Kheir MM, Shohat N, et al. Culture-Negative periprosthetic joint infection: an update on what to expect[J/OL]. JB JS Open Access, 2018, 3(3): e0060. DOI: 10.2106/JBJS.OA.17.00060.
[10]
Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty[J]. J Bone Joint Surg Am, 2003, 85-A Suppl 1: S75-S80.
[11]
Huang R, Hu CC, Adeli B, et al. Culture-negative Periprosthetic Joint Infection Does Not Preclude Infection Control[J]. Clin Orthop Relat Res, 2012, 470(10): 2717-2723.
[12]
Bejon P, Berendt A, Atkins BL, et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology[J]. J Antimicrob Chemother, 2010, 65(3): 569-575.
[13]
Malekzadeh D, Osmon DR, Lahr BD, et al. Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection[J]. Clin Orthop Relat Res, 2010, 468(8): 2039-2045.
[14]
Ibrahim MS, Twaij H, Haddad FS. Two-stage revision for the culture-negative infected total hip arthroplasty: a comparative study[J]. Bone Joint J, 2018, 100-B (1 Supple A): 3-8.
[15]
Mortazavi SM, Vegari D, Ho A, et al. Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure[J]. Clin Orthop Relat Res, 2011, 469(11): 3049-3054.
[16]
Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection[J]. N Engl J Med, 2007, 357(7): 654-663.
[17]
Hersh BL, Shah NB, Rothenberger SD, et al. Do culture negative periprosthetic joint infections remain culture negative？[J]. J Arthroplasty, 2019, 34(11): 2757-2762.
[18]
Bini VJ, Corzo-Pedroza M, Gonzales ZJ. Prosthetic joint infection caused by Candida lusitaniae: report of a unique case[J]. Acta Clin Belg, 2019, 74(4): 286-291.
[19]
Million M, Bellevegue L, Labussiere AS, et al. Culture-negative prosthetic joint arthritis related to Coxiella burnetii[J]. Am J Med, 2014, Aug 127(8): 786.e7-786.e10.
[20]
Patel R, Osmon DR, Hanssen AD. The diagnosis of prosthetic joint infection: current techniques and emerging technologies[J]. Clin Orthop Relat Res, 2005, Aug (437): 55-58.
[21]
Segawa H, Tsukayama DT, Kyle RF, et al. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections[J]. J Bone Joint Surg Am, 1999, 81(10): 1434-1445.
[22]
Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected, infected revision arthroplasty tissues. The Osiris collaborative study group. Oxford skeletal infection research and intervention service[J]. Arch Orthop Trauma Surg, 2000, 120(10): 570-574.
[23]
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections[J]. N Engl J Med, 2004, 351(16): 1645-1654.
[24]
Kim S, Bishop AR, Squire MW, et al. Mechanical, elution, and antibacterial properties of simplex bone cement loaded with vancomycin[J/OL]. J Mech Behav Biomed Mater, 2020, Mar (103): 103588. DOI: 10.1016/j.jmbbm.2019.103588.
[25]
Lee SH, Tai CL, Chen SY, et al. Elution and mechanical strength of Vancomycin-Loaded bone cement: in vitro study of the influence of brand combination[J/OL]. PLoS One, 2016, 11(11): e0166545. DOI: 10.1371/journal.pone.0166545.
[26]
Martínez-Moreno J, Merino V, Nácher A, et al. Antibiotic-loaded bone cement as prophylaxis in total joint replacement[J]. Orthop Surg, 2017, 9(4): 331-341.
[27]
Anagnostakos K. What do we (not) know about antibiotic-loaded hip spacers？[J]. Orthopedics, 2014, 37(5): 297-298.
[28]
Slane J, Gietman B, Squire M. Antibiotic elution from acrylic bone cement loaded with high doses of tobramycin and vancomycin[J]. J Orthop Res, 2018, 36(4): 1078-1085.
[29]
Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection[J]. Bone Joint J, 2013, 95-b(11): 1450-1452.
[30]
Bedair H, Goyal N, Dietz MJ, et al. A history of treated periprosthetic joint infection increases the risk of subsequent different site infection[J]. Clin Orthop Relat Res, 2015, 473(7): 2300-2304.
[31]
Shahi A, Deirmengian C, Higuera C, et al. Premature therapeutic antimicrobial treatments can compromise the diagnosis of late periprosthetic joint infection[J]. Clin Orthop Relat Res, 2015, 473(7): 2244-2249.
[32]
Zmistowski B, Della Valle C, Bauer TW, et al. Diagnosis of periprosthetic joint infection[J]. J Orthop Res, 2014, 32 Suppl 1: S98-S107.
[33]
Peel TN, Dylla BL, Hughes JG, et al. Improved diagnosis of prosthetic joint infection by culturing periprosthetic tissue specimens in blood culture bottles[J]. MBio, 2016, 7(1): e01715-e01776.
[34]
Zappe B, Graf S, Ochsner PE, et al. Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge[J]. Arch Orthop Trauma Surg, 2008, 128(10): 1039-1046.
[35]
Bedenčič K, Kavčič M, Faganeli N, et al. Does preoperative antimicrobial prophylaxis influence the diagnostic potential of periprosthetic tissues in hip or knee infections？[J]. Clin Orthop Relat Res, 2016, 474(1): 258-264.
[36]
Della Valle C, Parvizi J, Bauer TW, et al. American academy of orthopaedic surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee[J]. J Bone Joint Surg Am, 2011, 93(14): 1355-1357.
[37]
Parvizi J, Erkocak OF, Della Valle CJ. Culture-negative periprosthetic joint infection[J]. J Bone Joint Surg Am, 2014, 96(5): 430-436.
[38]
Larsen LH, Lange J, Xu Y, et al. Optimizing culture methods for diagnosis of prosthetic joint infections: a summary of modifications and improvements reported since 1995[J]. J Med Microbiol, 2012, 61(Pt 3): 309-316.
[39]
Peel TN, Spelman T, Dylla BL, et al. Optimal periprosthetic tissue specimen number for diagnosis of prosthetic joint infection[J]. J Clin Microbiol, 2017, 55(1): 234-243.
[40]
赵潇雄，曲铁兵．双血培养瓶培养法在关节置换术后假体周围感染诊断中的应用[J/CD]．中华关节外科杂志(电子版)，2017，11(5)：491-495.
[41]
Jitmuang A, Yuenyongviwat V, Charoencholvanich K, et al. Rapidly-growing mycobacterial infection: a recognized cause of early-onset prosthetic joint infection[J/OL]. BMC Infect Dis, 2017, 17(1): 802. DOI: 10.1186/s12879-017-2926-3.
[42]
Trampuz A, Piper KE, Hanssen AD, et al. Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination[J]. J Clin Microbiol, 2006, 44(2): 628-631.
[43]
Rothenberg AC, Wilson AE, Hayes JP, et al. Sonication of arthroplasty implants improves accuracy of periprosthetic joint infection cultures[J]. Clin Orthop Relat Res, 2017, 475(7): 1827-1836.
[44]
Kuiper JW, Van DM, Van Der Stappen J, et al. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections[J]. Acta Orthop, 2013, 84(6): 517-523.
[45]
Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America[J/OL]. Clin Infect Dis, 2013, 56(1): e1-e25. DOI: 10.1093/cid/cis803.
[1] 闫文, 谢兴文, 顾玉彪, 雷宁波, 马成, 于文霞, 高亚雄, 张磊. 微小RNA与全膝关节置换术后深静脉血栓的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 842-846.
[2] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[3] 李善武, 叶永杰, 王兵, 王子呓, 银毅, 孙官军, 张大刚. 胫骨高位截骨与单髁置换的早期疗效比较[J]. 中华关节外科杂志(电子版), 2023, 17(06): 882-888.
[4] 李辉, 吴奇, 张子琦, 张晗, 王仿, 许鹏. 日间全膝关节置换术早期疗效及标准化流程探索[J]. 中华关节外科杂志(电子版), 2023, 17(06): 889-892.
[5] 邓华梅, 袁札根, 曾德荣, 潘珊珊, 张葆青, 欧爱华, 曹学伟. 全膝关节置换术中气压止血带应用效果与影响因素分析[J]. 中华关节外科杂志(电子版), 2023, 17(06): 788-794.
[6] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[7] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[8] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[9] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[10] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[11] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[12] 卓徐鹏, 刘颖, 任菁菁. 感染性疾病与老年人低蛋白血症的相关性研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 896-899.
[13] 李静静, 翟蕾, 赵海平, 郑波. 多囊肾合并囊肿的多重耐药菌感染一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 920-923.
[14] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[15] 杨艳丽, 陈昱, 赵若辰, 杜伟, 马海娟, 许珂, 张莉芸. 系统性红斑狼疮合并血流感染的危险因素及细菌学分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 694-699.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号